0000000000524445

AUTHOR

Giovanna Tomaiuolo

showing 2 related works from this author

Engineering approaches in siRNA delivery.

2017

siRNAs are very potent drug molecules, able to silence genes involved in pathologies development. siRNAs have virtually an unlimited therapeutic potential, particularly for the treatment of inflammatory diseases. However, their use in clinical practice is limited because of their unfavorable properties to interact and not to degrade in physiological environments. In particular they are large macromolecules, negatively charged, which undergo rapid degradation by plasmatic enzymes, are subject to fast renal clearance/hepatic sequestration, and can hardly cross cellular membranes. These aspects seriously impair siRNAs as therapeutics. As in all the other fields of science, siRNAs management ca…

0301 basic medicine3003siRNAs Delivery vectors in vitro models Mathematical modeling Physical modelingDelivery vectors; In vitro models; Mathematical modeling; Physical modeling; SiRNAs; 3003Pharmaceutical ScienceNanotechnology02 engineering and technologyComputational biologyBiology03 medical and health sciencesDrug Delivery SystemsHumanssiRNAs; Delivery vectors; in vitro models; Mathematical modeling; Physical modelingRNA Small Interferingin vitro modelsPhysical modelingSettore ING-IND/34 - Bioingegneria IndustrialeHydrogelsDelivery vectorsModels Theoretical021001 nanoscience & nanotechnologyDelivery vectorsiRNAsClinical PracticeHydrogel030104 developmental biologyin vitro modelsiRNAMathematical modeling0210 nano-technologyBlood streamDrug Delivery SystemClearanceHumanInternational journal of pharmaceutics
researchProduct

Margination of Fluorescent Polylactic Acid-Polyaspartamide based Nanoparticles in Microcapillaries In Vitro: the Effect of Hematocrit and Pressure.

2017

The last decade has seen the emergence of vascular-targeted drug delivery systems as a promising approach for the treatment of many diseases, such as cardiovascular diseases and cancer. In this field, one of the major challenges is carrier margination propensity (i.e., particle migration from blood flow to vessel walls); indeed, binding of these particles to targeted cells and tissues is only possible if there is direct carrier–wall interaction. Here, a microfluidic system mimicking the hydrodynamic conditions of human microcirculation in vitro is used to investigate the effect of red blood cells (RBCs) on a carrier margination in relation to RBC concentration (hematocrit) and pressure drop…

Pharmaceutical ScienceNanoparticle02 engineering and technologyPolymeric nanoparticleHematocrit01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundDrug Delivery SystemsPolylactic acidDrug Discoveryαβ-poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)medicine.diagnostic_testMolecular StructureChemistry">l-aspartamide (PHEA)poly(ethylene glycol) (PEG)Microfluidic Analytical Techniques021001 nanoscience & nanotechnologypolymeric nanoparticlesBiochemistryHematocritmarginationChemistry (miscellaneous)Drug deliveryMolecular Medicine0210 nano-technologyDrug carrier">PolyestersIn Vitro Techniquesα β-poly-(N-2-hydroxyethyl)-D010402 general chemistryFluorescenceArticleMicrocirculationαβ-poly-(N-2-hydroxyethyl)-<span style="font-variant: small-caps;">d</span><span style="font-variant: small-caps;"></span><span style="font-variant: small-caps;">l</span>-aspartamide (PHEA); poly(lactic acid) (PLA); poly(ethylene glycol) (PEG); polymeric nanoparticles; marginationlcsh:QD241-441Rhodaminelcsh:Organic chemistrypoly(lactic acid) (PLA)PEG ratiomedicineHumansPhysical and Theoretical ChemistryParticle Sizeα β-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA)αβ-poly-(N-2-hydroxyethyl)-RhodaminesMicrocirculationOrganic Chemistry0104 chemical sciencesBiophysicsNanoparticles">dPeptidesMolecules (Basel, Switzerland)
researchProduct